Inside San Francisco's Hottest Peptide Club: Where Tech Elites Experiment With Gray-Market Drugs

On April 12, more than 100 people gathered at the AGI House in San Francisco's Twin Peaks neighborhood for the California Peptide Club, an invite-only event celebrating peptides—the self-optimization substances that have exploded in popularity among tech workers and celebrities. Organized by 24-year-old Julius Ritter, who credits peptides with solving his bottom-one-percent testosterone levels, the event drew clinicians, manufacturers, Stanford researchers, and "peptide curious" attendees eager to share protocols and inject themselves with research chemicals. The gathering revealed a thriving underground community: about half the 100+ attendees had already used peptides, and every single person who raised their hand had injected themselves with research-only compounds labeled "not for human consumption."

The event showcased the murky reality of peptide culture: a world where anecdotal testimonials replace rigorous medical data, where attendees can't easily distinguish doctors from self-taught experimenters (one speaker later revealed himself to be an ophthalmologist, not a peptide specialist), and where the regulatory gray zone makes sourcing sketchy. While some peptides like Ozempic are FDA-approved, most exist in legal limbo, sold as "research chemicals" from compounding pharmacies or Chinese labs. Three days after the event, RFK Jr. announced plans to reclassify a dozen previously banned peptides—a move that could legitimize substances like BPC-157 and Semax. The peptide craze has entered mainstream consciousness: Google searches for "peptide" overtook "pickleball" in April, and A-listers like Joe Rogan and Jennifer Aniston fuel FOMO among the uninitiated.

Ritter's event functioned as both community-building and risk normalization. Speakers shared success stories—a functional medicine practitioner crediting peptides with avoiding opioids, a frozen yogurt entrepreneur calling Semax an "absolute game-changer"—while a French volunteer demonstrated live self-injection on stage to dozens of recording phones. Yet serious dangers lurked beneath the cheerful Kahoot quiz and peptide-themed mini fridge giveaway. Last summer, two women hospitalized in critical condition requiring ventilators received peptide injections at a Las Vegas aging festival. Unknown-source peptides pose contamination risks, and some have been linked to long-term cancer risks. Notably, safety concerns were barely discussed at the gathering. Ritter, planning monthly events, is "trying to figure out the legality" of offering injections at future clubs—a revealing admission that even the organizer recognizes he may be operating in ethically and legally uncertain territory.